← FDA Drug Approvals (Drugs@FDA)
AMPICILLIN AND SULBACTAM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ISTITUTO BIO ITA SPA · Approved 2005-11-29
Drug application
- FDA Application #
ANDA065222- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- AMPICILLIN AND SULBACTAM
- Generic name
- AMPICILLIN SODIUM AND SULBACTAM SODIUM
- Active ingredients
- AMPICILLIN SODIUM; SULBACTAM SODIUM
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- ISTITUTO BIO ITA SPA
- Manufacturer
- NorthStar Rx, LLC
- First approval
- 2005-11-29
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown